Status:
COMPLETED
Point of Care Ultrasonography Assessment During Pulmonary Hypertension Clinic
Lead Sponsor:
Soroka University Medical Center
Conditions:
POCUS Assessment During Ambulatory PAH Clinic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: Changes occurring in the pulmonary vascularity imparts changes to the right heart in patients with pulmonary arterial hypertension (PAH). Importantly changes in RV function correlates with...
Detailed Description
The investigators included patients if they were diagnosed with group 1 PH (PAH), as defined by the updated clinical classification of PH and provided informed consent. Patients were excluded if diagno...
Eligibility Criteria
Inclusion
- All patients with PAH defined by the Updated clinical classification of pulmonary hypertension criteria.
- Age ≥ 18
- Baseline values from right-heart catheterization results for the definite diagnosis of PH: Hemodynamic inclusion: resting mPAP \> 25mmHg, PCWP \< 15mmHg, and PVR \> 3 Woods Units.
Exclusion
- Inability to give informed consent.
- Clear evidence of Group 2-5 PH. We will also exclude patients with PAH on the basis of congenital heart disease, liver cirrhosis or suspected pulmonary veno-occlusive disease.
Key Trial Info
Start Date :
January 14 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT05332847
Start Date
January 14 2018
End Date
June 30 2021
Last Update
April 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Soroka Medical Center
Beersheba, Negev, Israel, 85510